Oxycontin

Newark narcotics network supplied OxyContin to Bronx, N.Y., ring

February 4, 2008 -- TRENTON – New Jersey Attorney General Anne Milgram and Criminal Justice Director Gregory A. Paw announced that a mother and son pleaded guilty today to racketeering charges for their roles in a Newark-based narcotics ring that distributed millions of dollars a year in illegal prescription painkillers such as OxyContin.    » read more »

Funding comes from prescription drug plea agreement

November 15, 2007 -- Richmond – Virginia Governor Timothy M. Kaine today announced that the Virginia Prescription Monitoring Program (PMP) will receive $20 million as part of the plea agreement involving the Purdue Frederick Company, Inc. John Brownlee, United States Attorney for the Western District of Virginia, will present the funds at PMP’s annual conference on Nov. 16.    » read more »

October 05, 2007 -- Kentucky Attorney General Greg Stumbo today announced the filing of a lawsuit against Purdue Pharma, the manufacturer of OxyContin, a highly abused narcotic.

The lawsuit alleges that Purdue Pharma misrepresented the risks of using OxyContin and seeks to recover damages suffered state and county governments related to widespread addiction caused by the drug.

(Click here for a copy of the Complaint: http://tinyurl.com/2qyfky)    » read more »

September 28, 2007 -- Oregon Attorney General Hardy Myers today announced that the Department of Justice (DOJ) Medicaid Fraud Control Unit has reached a settlement with the Purdue Frederick Company, Inc., a New York Corporation ("Purdue Frederick") and Purdue Pharma L.P., a Delaware limited partnership ("Purdue") which are associated entities engaged in the manufacture, marketing and distribution of OxyContin, an extended-release form of the painkiller Oxycodone.    » read more »

Settlement resolves civil charges caused by company’s misbranding of OxyContin

September 21, 2007 -- TALLAHASSEE, FL – Florida Attorney General Bill McCollum today announced that his Medicaid Fraud Control Unit has joined a national settlement with the Purdue Frederick Company, Inc., a New York corporation, and Purdue Pharma, L.P. a Delaware Limited Partnership. The companies will pay more than $2 million to the State of Florida to resolve civil claims related to the manufacture, marketing and distribution of OxyContin.    » read more »

September 20, 2007 -- (Boise) - The State of Idaho has recovered $652,130 as a result of a civil settlement involving alleged misbranding of the prescription drug OxyContin, Idaho Attorney General Lawrence Wasden said today. Wasden said his office and the Idaho Department of Health and Welfare Medicaid Division joined in a multi-state settlement with two associated businesses engaged in the manufacture, marketing, and distribution of OxyContin, an extended-release form of Oxycodone.    » read more »

September 18, 2007 -- OLYMPIA – Washington Attorney General Rob McKenna announced today that the state's Medicaid program will be reimbursed nearly $2.7 million as part of a settlement with drug manufacturers Purdue Pharma and Purdue Frederick Company. The settlement stems from allegations the company improperly marketed the pain medication OxyContin to health providers.    » read more »

September 18, 2007 -- HARRISBURG - A $5,078,436 settlement has been reached with The Purdue Frederick Company, Inc. and Purdue Pharma, L.P., manufacturers of OxyContin, for improperly marketing the highly addictive pain medication to health care providers.

Pennsylvania Attorney General Tom Corbett said the money is part of a $160 million multi-state civil lawsuit settlement to compensate state and federal Medicaid programs for damages caused by the misbranding of OxyContin from 1995 through 2005.    » read more »

September 18, 2007 -- Carson City, NV - Nevada Attorney General Catherine Cortez Masto announced today that her office has reached a settlement with The Purdue Frederick Company, Inc., a New York corporation, and Purdue Pharma, L.P., a Delaware limited partnership, which are associated entities engaged in the manufacture, marketing, and distribution of OxyContin, an extended-release form of oxycodone.

Under the terms of the settlement, the State of Nevada recovered $1,047,787.19 to recoup damages to the Nevada Medicaid program as well as damages for investigative costs and penalties.    » read more »

September 17, 2007 -- MADISON - Wisconsin's Medicaid Program will be compensated for Purdue Pharmaceuticals' fraudulent practices relating to the sale of OxyContin, Wisconsin Attorney General J.B. Van Hollen announced today. The payment is part of a settlement agreement the Wisconsin Department of Justice (DOJ) and the Wisconsin Department of Health and Family Services (DHFS) have reached with The Purdue Frederick Company, Inc., a New York corporation, and Purdue Pharma, L.P., a Delaware limited partnership (collectively "Purdue").    » read more »

Cuomo’s Medicaid Fraud Control Unit represented NY and 46 other states to disburse funds from $160 million in damages

ALBANY, NY (September 13, 2007) New York Attorney General Andrew M. Cuomo today announced New York State has received $7.26 million in damages from the makers of OxyContin for misrepresenting the dangers of the drug.    » read more »

September 14, 2007 -- BOSTON – Massachusetts Attorney General Martha Coakley’s office has reached a settlement with Purdue Pharma, LP and its subsidiary The Purdue Frederick Company, Inc., whereby the companies have paid $7,981,715.93 to the Massachusetts Medicaid program (MassHealth) to settle claims that Purdue engaged in improper marketing of the highly addictive pain medication OxyContin, resulting in damages to the Commonwealth.    » read more »

September 05, 2007 --BOSTON - Massachusetts Attorney General Martha Coakley’s Office is now accepting grant applications from qualified municipal coalitions and collaboratives throughout the Commonwealth to subsidize programs directed at combating substance abuse and addiction. The funding for the grants stems from a May 2007 multistate consent judgment against Purdue Pharma, the maker of the narcotic pain medication OxyContin. As part of the judgment, Massachusetts received $949,500.    » read more »

$4.4 Million in Assets Seized - Newark Narcotics Network Supplied OxyContin to Bronx, N.Y., Distribution Ring

August 2, 2007 -- TRENTON – New Jersey Attorney General Anne Milgram and Criminal Justice Director Gregory A. Paw announced that a state grand jury today returned an indictment charging 19 alleged members of a Newark-based narcotics ring, including its leader, with first-degree racketeering and other crimes in connection with the ring’s distribution of millions of dollars a year in illegal prescription painkillers such as OxyContin.    » read more »

July 31, 2007 -- Connecticut Attorney General Richard Blumenthal today, in congressional testimony, demanded federal action on his three-year-old petition to require stronger label warnings on OxyContin and urged stronger criminal sanctions to prevent future tragedy.

More than 300 people have died from OxyContin overdoses, while Purdue Pharma has made hundreds of millions of dollars in profits, Blumenthal said.    » read more »